Myxoid degeneration of ovarian tumors represents a rare distinctive benign ovarian stromal neoplasm that occurs predominantly in young women and is hormonally inactive. According to recent bibliography, pathogenesis remains controversial. Many conducted studies express the strong belief adjusting myxoid ovarian tumors with genetic abnormalities. Therapeutic mapping is associated with histologic confirmation of the lesion. In cases of premenopausal patients, fertility preservation consists of ultimate scope. Abdominal MRI (magnetic resonance imaging) along with transvaginal ultrasound can differentiate and depict all preoperative imaging findings. Myxoid degenerated ovarian tumors can be malignant transformed into myxoid leiomyosarcomas with extremely metastatic possibilities. Meticulous atomic history, proper laboratory and imaging findings reflect successful key concerning ultimate diagnosis and treatment.

Fibroids represent benign tumors consistingof smooth muscle cells and fibrous connective tissue. In most of cases, they develop inside the uterine cavity.It is estimated that 70-80% of women will develop fibroids in their lifetime-however, not everyone will develop symptoms or require treatment.Cause of uterine fibroids is not known, although studies demonstrate there may be a genetic component. There is no food or external exposure that a woman can have that can cause her to develop fibroids. Ultimate goal remains fertility preservation, especially in young premenopausal patients.Laparoscopic approach represents proper surgical option depending on the age of the patient, the size and anatomic location of the uterine fibroids.